Corporate

  • April 09, 2025

    Mich. Panel: Gilead Immune From Recalled COVID Drug Suit

    Gilead Sciences Inc. has escaped a lawsuit pinning a man's strokes on doses of an antiviral COVID-19 medication that were later recalled, with a Michigan state appeals court finding that the company is protected by a public health law's liability shield.

  • April 09, 2025

    Chancery Lets Paramount Investors Probe Skydance Deal

    Delaware's top Chancery magistrate said Wednesday that Paramount Global stockholders probing the company's proposed $8 billion Skydance Media merger can have access to dozens of documents, but kept sealed further details in a transcript of a hearing closed to the public for at least five additional days.

  • April 09, 2025

    House Dems Probe Musk's Alleged Conflicts Of Interest

    Democrats on the House Oversight Committee wrote to four federal agencies seeking answers to how they plan to ensure that Elon Musk isn't using his position at the Department of Government Efficiency to exploit them and enrich himself in violation of federal ethics rules.

  • April 09, 2025

    Country's Largest Egg Producer Discloses DOJ Price Probe

    Cal-Maine Foods Inc., which bills itself as the country's largest producer and distributor of fresh shell eggs, on Tuesday became the first company to disclose being targeted by a U.S. Department of Justice civil probe into spiking egg prices.

  • April 09, 2025

    Apple Agrees To Revise Some Worker Policies In NLRB Deal

    Apple will revise some parts of its confidentiality agreement and other worker policies as part of an unfair labor practice settlement at the National Labor Relations Board, according to the deal, which requires the tech giant to put up a post indefinitely on a public-facing website.

  • April 09, 2025

    2nd Circ. Allows Takeda To Appeal Actos Antitrust Class Cert.

    A split Second Circuit will allow Takeda Pharmaceuticals Co. to immediately appeal a New York federal judge's ruling certifying two classes of direct purchasers and end payors in consolidated antitrust actions accusing the company of unlawfully inflating the price of its diabetes treatment Actos by delaying the entry of generic alternatives.

  • April 09, 2025

    House Slates CFPB Payment, Overdraft Rules For Repeal

    The House on Wednesday voted to overturn two Biden-era Consumer Financial Protection Bureau rules aimed at increasing oversight of larger digital payment providers and curbing big-bank overdraft fees, setting the pair up for final repeal at the White House.

  • April 09, 2025

    Miami Dolphins Win Arbitration Bid In Crowd Brawl Suit

    A Florida appellate panel on Wednesday sent to arbitration a lawsuit attempting to hold the Miami Dolphins liable for injuries a woman suffered after a fight broke out in the stands, ruling that although the plaintiff did not purchase the tickets, the arbitration clause was still valid.

  • April 09, 2025

    Trump Halts Reciprocal Tariffs For 90 Days, Ups China Rates

    President Donald Trump has ordered a 90-day pause on reciprocal tariffs for certain countries hours after they took effect, except for China, whose imports he said now face an increased tariff of 125%, according to a Wednesday social media post.

  • April 09, 2025

    CrowdStrike Says Outage 'Unfortunate,' Not Securities Fraud

    CrowdStrike Holdings Inc. has urged a Texas federal judge to toss a shareholder suit accusing it of mischaracterizing the measures it was taking to prevent a system crash, which caused its stock price to plummet after the platform experienced a massive outage last year, saying the outage was "unfortunate ... but it did not reveal any securities fraud."

  • April 09, 2025

    SafeMoon CEO Flags DOJ Crypto Memo In Bid For Dismissal

    The CEO of crypto firm SafeMoon alerted a Brooklyn federal judge Wednesday to a U.S. Justice Department directive not to pursue charges related to digital assets under the Securities Exchange Act or Commodity Exchange Act, suggesting that the judge should dismiss his investor fraud case.

  • April 09, 2025

    Winston & Strawn Leads Fintech-Focused SPAC's $240M IPO

    Special purpose acquisition company Titan Acquisition Corp. began trading Wednesday after pricing a $240 million initial public offering in pursuit of a merger with a fintech or related business, represented by Winston & Strawn LLP and underwriters' counsel Ellenoff Grossman & Schole LLP.

  • April 09, 2025

    Florida Won't Hire Law Firms With DEI Initiatives, AG Says

    The state of Florida will no longer hire law firms with diversity, equity and inclusion programs to serve as outside general counsel, according to a new memo from Attorney General James Uthmeier.

  • April 09, 2025

    Roberts Pauses Rehiring Of Fired NLRB, MSPB Members

    Chief Justice John Roberts temporarily paused an en banc D.C. Circuit's order reinstating two fired members of the National Labor Relations Board and the Merit Systems Protection Board on Wednesday, in a dispute that challenges a 90-year-old U.S. Supreme Court ruling protecting certain government officials from presidential removal.

  • April 09, 2025

    Ex-Mars Executive Faces Forfeiture Bid In $28M Fraud Case

    The U.S. Department of Justice wants the former global price risk manager of a subsidiary of candy maker Mars Inc. to forfeit a Connecticut home plus accounts at three financial firms to help offset $28 million in alleged fraud proceeds.

  • April 09, 2025

    Ex-Qualcomm Executive Convicted Of $180M Fraud

    A federal jury in San Diego has found a former executive at Qualcomm guilty of defrauding the chipmaker by creating a fake company, concealing his connection to it and selling it to Qualcomm for $180 million.

  • April 08, 2025

    Jazz Agrees To Pay $145M To Settle Xyrem Antitrust Fight

    Jazz Pharmaceuticals has agreed to pay $145 million to resolve antitrust litigation accusing it of working with its rival Hikma Pharmaceuticals to stave off generic competitors to Jazz's narcolepsy drug Xyrem, the Ireland-based pharmaceutical company revealed Tuesday.

  • April 08, 2025

    Ex-Outcome CEO, Co-Founder Challenge $1B Fraud Convictions

    Outcome Health's former CEO and co-founder are challenging their convictions for lying about the company's capabilities and value in a $1 billion fraud, arguing a legally deficient fraud theory, unfair narrative evidence and the government's admitted pre-trial asset over-restraint warrant unwinding the jury's verdict.

  • April 08, 2025

    4th Circ. Affirms Dismissal Of IonQ Shareholder Fraud Suit

    The Fourth Circuit on Tuesday declined to revive a shareholder class action against quantum computer developer IonQ, holding that the plaintiffs' reliance on a short seller's report didn't clear the "high bar" for bringing their securities fraud claims against the company.

  • April 08, 2025

    Crypto Investor Sues In Del. Alleging $16M Pump, Dump Loss

    Cayman Islands-registered cryptocurrency venture Hash Asset Management Ltd. sued two other crypto entities and four individuals in Delaware's Court of Chancery on Tuesday, alleging a "pump and dump" scheme that saw more than $16 million allegedly siphoned away in violation of token deposit and lending agreements.

  • April 08, 2025

    5th Circ. Orders New Trial In $140M Healthcare Fraud Case

    A Fifth Circuit panel shot down a bid from a suspect in a $140 million healthcare fraud scheme to forestall a second trial after alleged prosecutorial misconduct sank the first, finding the government hadn't intentionally withheld evidence.

  • April 08, 2025

    Ex-Google Engineer Unlikely To Beat AI Trade Secrets Charges

    A California federal judge indicated Tuesday that he's unlikely to toss economic espionage charges against an ex-Google engineer accused of stealing artificial intelligence trade secrets to benefit startups in China, but said he "can't shake the feeling" that prosecutors wouldn't have brought the case if it involved a different country.

  • April 08, 2025

    Expert And 'Worthlessness Theory' Ejected In Valsartan MDL

    Patients and insurers who claim they were ripped off when purchasing the contaminated blood pressure medication Valsartan won't be able to argue that the drug was worthless as a matter of law, a New Jersey federal judge overseeing the multidistrict litigation has ruled, casting doubt that the plaintiffs will secure a full refund for their purchase.

  • April 08, 2025

    Attys In Javice Case Warned About Post-Trial Juror Contact

    A Manhattan federal judge on Monday cautioned attorneys in the criminal case against Frank founder Charlie Javice to adhere to the rules governing post-trial contact with jurors who convicted her and another executive on fraud and conspiracy charges stemming from JPMorgan Chase & Co.'s ill-fated acquisition of the educational startup.

  • April 08, 2025

    Feds Sue Wash. Company Over Barge's $1M Oil Spill Cleanup

    The U.S. Department of Justice and the U.S. Coast Guard have sued a Washington state barge owner for allegedly violating federal laws related to an oil spill that the government said cost more than $1 million in salvage and remediation costs.

Expert Analysis

  • 6 Principles For De-Risking In This Era Of Uncertainty

    Author Photo

    Companies can emerge from the current period of disruptive transformation stronger than ever by embracing strategies that enable them to methodically evaluate risk, adapt to change without losing purpose, focus on customer value and find competitive advantages amid uncertainty, says David McVeigh at Axiom.

  • What 2nd Trump Admin Means For Ship Pollution Compliance

    Author Photo

    As the second Trump administration's civil and criminal enforcement policies take shape, the maritime industry must ensure it complies with both national and international obligations to prevent oil pollution from seagoing vessels — with preventive efforts and voluntary disclosures being some of the best options for mitigating risk, say attorneys at Holland & Knight.

  • 23andMe Case Highlights Privacy Complexities In Ch. 11

    Author Photo

    Attorneys at Pryor Cashman discuss the interplay between a sale of personally identifiable information and bankruptcy law in light of genetics and health company 23andMe's recent filing for Chapter 11 relief.

  • Mass. AG Emerges As Key Player In Consumer Protection

    Author Photo

    Through enforcement actions and collaborations with other states — including joining a recent amicus brief decrying the defunding of the Consumer Financial Protection Bureau — Massachusetts Attorney General Andrea Campbell has established herself as a thought leader for consumer protection and corporate accountability, say attorneys at Troutman Pepper.

  • SEC Confidential Review Process Provides Issuers Flexibility

    Author Photo

    The U.S. Securities and Exchange Commission's recently announced enhancements to the process for confidentially submitting draft registration statements will be immediately impactful for issuers seeking to access the public capital markets, and should provide more grounds to explore and plan public offerings, say attorneys at Lowenstein Sandler.

  • Series

    Birding Makes Me A Better Lawyer

    Author Photo

    Observing and documenting birds in their natural habitats fosters patience, sharpens observational skills and provides moments of pure wonder — qualities that foster personal growth and enrich my legal career, says Allison Raley at Arnall Golden.

  • Measuring And Mitigating Harm From Discriminatory Taxes

    Author Photo

    In response to new tariffs and other recent "America First Trade Policy" pronouncements, corporations should assess and take steps to minimize their potential exposure to discriminatory and reciprocal tax measures that are likely to come, say economists at Charles River Associates.

  • How Del. Law Rework Limits Corporate Records Requests

    Author Photo

    Newly enacted amendments to a section of the Delaware General Corporation Law that allows stockholders and beneficial owners to demand inspection of Delaware corporations' books and records likely curtails the scope of such inspections and aids defendants in framing motions to dismiss at the pleading stage, says Jonathan Richman at Brown Rudnick.

  • Series

    Calif. Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    Among the most notable developments in California banking in the first quarter of the year, regulators and legislators issued regulations interpreting debt collection laws, stepped up enforcement actions, and expanded consumer protections for those affected by wildfires, says Stephen Britt at Severson & Werson.

  • How The ESG Investing Rule Survived Loper Bright, For Now

    Author Photo

    A Texas federal court's recent decision in Utah v. Micone upholding the U.S. Department of Labor's 2022 ESG investing rule highlights how regulations can withstand the post-Loper Bright landscape when an agency's interpretation of its statutorily determined boundaries is not granted deference, say attorneys at Miller & Chevalier.

  • Series

    Adapting To Private Practice: From DOJ Leadership To BigLaw

    Author Photo

    The move from government service to private practice can feel like changing one’s identity, but as someone who has left the U.S. Department of Justice twice, I’ve learned that a successful transition requires patience, effort and the realization that the rewards of practicing law don’t come from one particular position, says Richard Donoghue at Pillsbury.

  • In-House Expert Testimony Is Tricky, But Worth Considering

    Author Photo

    Litigation counsel often reject the notion of designating in-house personnel to provide expert opinion testimony at trial, but dismissing them outright can result in a significant missed opportunity, say David Ben-Meir at Ben-Meir Law and Martin Pitha at Lillis Pitha.

  • Issues To Watch At ABA's Antitrust Spring Meeting

    Author Photo

    Attorneys at Freshfields consider the future of antitrust law and competition enforcement amid agency leadership changes and other emerging developments likely to dominate discussion at the American Bar Association's Antitrust Spring Meeting this week.

  • Series

    NY Banking Brief: All The Notable Legal Updates In Q1

    Author Photo

    The most noteworthy developments from the first quarter of the year in New York financial services include newly proposed regulations on overdraft fees, a groundbreaking settlement by the state attorney general, and a potentially precedent-setting opinion regarding the Electronic Fund Transfer Act, say attorneys at Quinn Emanuel.

  • Nev. Fraud Ruling Raises Stakes For Proxy Battles

    Author Photo

    Though a Nevada federal court’s recent U.S. v. Boruchowitz decision involved unusual facts, the court's ruling that board members can be defrauded of their seat through misrepresentations increases fraud risks in more typical circumstances involving board elections, especially proxy fights, say attorneys at ArentFox Schiff.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Corporate archive.
Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!